A detailed history of Parisi Gray Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Parisi Gray Wealth Management holds 3,761 shares of ABBV stock, worth $676,980. This represents 0.25% of its overall portfolio holdings.

Number of Shares
3,761
Previous 3,622 3.84%
Holding current value
$676,980
Previous $621,000 19.48%
% of portfolio
0.25%
Previous 0.22%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$163.84 - $199.33 $22,773 - $27,706
139 Added 3.84%
3,761 $742,000
Q2 2024

Jul 15, 2024

BUY
$154.79 - $180.76 $43,031 - $50,251
278 Added 8.31%
3,622 $621,000
Q1 2024

Apr 15, 2024

BUY
$159.82 - $182.1 $21,735 - $24,765
136 Added 4.24%
3,344 $608,000
Q4 2023

Jan 18, 2024

BUY
$137.6 - $154.97 $4,403 - $4,959
32 Added 1.01%
3,208 $497,000
Q3 2023

Oct 10, 2023

BUY
$133.59 - $154.65 $33,664 - $38,971
252 Added 8.62%
3,176 $473,000
Q1 2023

Apr 11, 2023

BUY
$144.61 - $166.54 $24,583 - $28,311
170 Added 6.17%
2,924 $465,000
Q4 2022

Jan 23, 2023

BUY
$138.31 - $165.87 $7,745 - $9,288
56 Added 2.08%
2,754 $0
Q3 2022

Oct 19, 2022

BUY
$134.21 - $153.93 $3,489 - $4,002
26 Added 0.97%
2,698 $362,000
Q2 2022

Jul 25, 2022

BUY
$137.62 - $174.96 $3,440 - $4,374
25 Added 0.94%
2,672 $409,000
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $263 - $327
-2 Reduced 0.08%
2,647 $429,000
Q4 2021

Feb 08, 2022

BUY
$107.43 - $135.93 $9,883 - $12,505
92 Added 3.6%
2,649 $359,000
Q3 2021

Nov 16, 2021

BUY
$106.4 - $120.78 $3,617 - $4,106
34 Added 1.35%
2,557 $279,000
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $2,945 - $3,281
28 Added 1.12%
2,523 $284,000
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $5,626 - $6,194
55 Added 2.25%
2,495 $270,000
Q4 2020

Feb 09, 2021

BUY
$80.49 - $108.67 $196,395 - $265,154
2,440 New
2,440 $261,000
Q3 2020

Nov 10, 2020

SELL
$85.91 - $100.83 $181,270 - $212,751
-2,110 Closed
0 $0
Q2 2020

Jul 27, 2020

BUY
$73.37 - $98.18 $154,810 - $207,159
2,110 New
2,110 $207,000
Q2 2019

Jul 19, 2019

SELL
$65.7 - $83.98 $21,089 - $26,957
-321 Closed
0 $0
Q2 2018

Aug 13, 2018

SELL
$89.78 - $106.23 $269 - $318
-3 Reduced 0.93%
321 $31,000
Q1 2018

May 11, 2018

BUY
$92.01 - $123.21 $276 - $369
3 Added 0.93%
324 $29,000
Q4 2017

Feb 13, 2018

BUY
$89.56 - $98.21 $28,748 - $31,525
321
321 $32,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Parisi Gray Wealth Management Portfolio

Follow Parisi Gray Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parisi Gray Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Parisi Gray Wealth Management with notifications on news.